@article{8d768571ae31441cb3be054802e383e6,
title = "Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease",
keywords = "Alzheimer's disease (AD), Amyloid, Amyloid precursor protein (APP), Estrogen, Protein phosphorylation, Secretase",
author = "Sam Gandy",
note = "Funding Information: This work was supported by the USPHS, the New York State Office of Mental Health, the Research Foundation for Mental Hygiene, and the Farber Family Foundation. Dr. Gandy has received extramural support from (a) the Women{\textquoteright}s Health Research Institute of Wyeth-Ayerst Research, a division of American Home Products Corporation, (b) Pfizer/Eisai, and (c) Andrx, and he has received consulting fees from (a) Parke-Davis Pharmaceuticals (now Pfizer Ann Arbor), (b) F. Hoffman La Roche (Basel), and The Pharmacia Corporation. ",
year = "2002",
month = nov,
doi = "10.1016/S0197-4580(02)00125-2",
language = "English",
volume = "23",
pages = "1009--1016",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "6",
}